OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The dawn of mRNA vaccines: The COVID-19 case
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 511-520
Open Access | Times Cited: 385
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 511-520
Open Access | Times Cited: 385
Showing 26-50 of 385 citing articles:
Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications
Liwei Wang, Di Wang, Zhaoming Ye, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 56
Liwei Wang, Di Wang, Zhaoming Ye, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 56
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 56
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 56
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 43
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 43
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis
Sasha E. Larsen, Jesse H. Erasmus, Valerie A. Reese, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 130-130
Open Access | Times Cited: 41
Sasha E. Larsen, Jesse H. Erasmus, Valerie A. Reese, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 130-130
Open Access | Times Cited: 41
Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1127-1127
Open Access | Times Cited: 40
Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1127-1127
Open Access | Times Cited: 40
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing
Min Qiu, Yamin Li, Hanan Bloomer, et al.
Accounts of Chemical Research (2021) Vol. 54, Iss. 21, pp. 4001-4011
Closed Access | Times Cited: 98
Min Qiu, Yamin Li, Hanan Bloomer, et al.
Accounts of Chemical Research (2021) Vol. 54, Iss. 21, pp. 4001-4011
Closed Access | Times Cited: 98
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Javier T. Granados‐Riveron, Guillermo Aquino‐Jarquín
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111953-111953
Open Access | Times Cited: 93
Javier T. Granados‐Riveron, Guillermo Aquino‐Jarquín
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111953-111953
Open Access | Times Cited: 93
Virus‐Mimicking Cell Membrane‐Coated Nanoparticles for Cytosolic Delivery of mRNA
Joon Ho Park, Animesh Mohapatra, Jiarong Zhou, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 2
Open Access | Times Cited: 89
Joon Ho Park, Animesh Mohapatra, Jiarong Zhou, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 2
Open Access | Times Cited: 89
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
An‐Katrien Minnaert, Helena Vanluchene, R Verbeke, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113900-113900
Open Access | Times Cited: 85
An‐Katrien Minnaert, Helena Vanluchene, R Verbeke, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113900-113900
Open Access | Times Cited: 85
Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
Wei Wang, Shuo Feng, Zhuyifan Ye, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 6, pp. 2950-2962
Open Access | Times Cited: 78
Wei Wang, Shuo Feng, Zhuyifan Ye, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 6, pp. 2950-2962
Open Access | Times Cited: 78
Metal-Organic Frameworks (MOFs)-Based Nanomaterials for Drug Delivery
Mohammad Reza Saeb, Navid Rabiee, Masoud Mozafari, et al.
Materials (2021) Vol. 14, Iss. 13, pp. 3652-3652
Open Access | Times Cited: 71
Mohammad Reza Saeb, Navid Rabiee, Masoud Mozafari, et al.
Materials (2021) Vol. 14, Iss. 13, pp. 3652-3652
Open Access | Times Cited: 71
Nanotechnology in drug and gene delivery
Selma Hamimed, Marwa Jabberi, Abdelwaheb Chatti
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 7, pp. 769-787
Open Access | Times Cited: 59
Selma Hamimed, Marwa Jabberi, Abdelwaheb Chatti
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 7, pp. 769-787
Open Access | Times Cited: 59
Progress towards the Development of a Universal Influenza Vaccine
Wen-Chien Wang, Ekramy E. Sayedahmed, Suryaprakash Sambhara, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1684-1684
Open Access | Times Cited: 57
Wen-Chien Wang, Ekramy E. Sayedahmed, Suryaprakash Sambhara, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1684-1684
Open Access | Times Cited: 57
Lipid carriers for mRNA delivery
Wanting Zhang, Yuxin Jiang, Yonglong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4105-4126
Open Access | Times Cited: 57
Wanting Zhang, Yuxin Jiang, Yonglong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4105-4126
Open Access | Times Cited: 57
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy
Chi Zhang, Yifan Ma, Jingjing Zhang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1943-1943
Open Access | Times Cited: 54
Chi Zhang, Yifan Ma, Jingjing Zhang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1943-1943
Open Access | Times Cited: 54
An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates
Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, et al.
Biomaterials (2022) Vol. 286, pp. 121570-121570
Open Access | Times Cited: 49
Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, et al.
Biomaterials (2022) Vol. 286, pp. 121570-121570
Open Access | Times Cited: 49
Effective mRNA Protection by Poly(l ‐ornithine) Synergizes with Endosomal Escape Functionality of a Charge‐Conversion Polymer toward Maximizing mRNA Introduction Efficiency
Anjaneyulu Dirisala, Satoshi Uchida, Junjie Li, et al.
Macromolecular Rapid Communications (2022) Vol. 43, Iss. 12
Closed Access | Times Cited: 44
Anjaneyulu Dirisala, Satoshi Uchida, Junjie Li, et al.
Macromolecular Rapid Communications (2022) Vol. 43, Iss. 12
Closed Access | Times Cited: 44
Lymph node-targeting nanovaccines for cancer immunotherapy
Qiu Wang, Zhe Wang, Xinxin Sun, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 102-122
Closed Access | Times Cited: 43
Qiu Wang, Zhe Wang, Xinxin Sun, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 102-122
Closed Access | Times Cited: 43
Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Yinan Ding, Luhong Wang, Han Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 42
Yinan Ding, Luhong Wang, Han Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 42
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
Chutamath Sittplangkoon, Mohamad‐Gabriel Alameh, Drew Weissman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Chutamath Sittplangkoon, Mohamad‐Gabriel Alameh, Drew Weissman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, et al.
Nano Convergence (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, et al.
Nano Convergence (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Development and applications of mRNA treatment based on lipid nanoparticles
Zhe Wang, Wanting Ma, Xingxing Fu, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108130-108130
Closed Access | Times Cited: 29
Zhe Wang, Wanting Ma, Xingxing Fu, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108130-108130
Closed Access | Times Cited: 29
An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
Rahul G Ingle, Wei‐Jie Fang
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 29
Rahul G Ingle, Wei‐Jie Fang
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 29
An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109934-109934
Open Access | Times Cited: 27
Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109934-109934
Open Access | Times Cited: 27
